Zaloguj się

Gotowe bibliografie tematyczne / Trials / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Trials.

Artykuły w czasopismach na temat „Trials”

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 25 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Trials”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Rujuta, Saksena, and M. Mehnert Janice. "Ignorance is not bliss: The importance of publishing negative trials." Biohelikon 2, no. 1 (2014): 1–3. https://doi.org/10.5281/zenodo.814311.

Pełny tekst źródła

Streszczenie:

It is not surprising that, in medicine, positive trials tend to generate more excitement compared with negative trials. Positive studies may be perceived as more likely to change the scope of one’s clinical practice. In general, negative studies attract less attention from different parties, including authors, editors, peer-reviewers, physicians, and readers of medical literature. Indeed, industry sponsors and principal investigators may hesitate to publish negative studies if critical acclaim of the work is not anticipated.

Style APA, Harvard, Vancouver, ISO itp.

2

Van Der Weyden, Martin B. "Trials on trial." Medical Journal of Australia 175, no. 5 (2001): 241. http://dx.doi.org/10.5694/j.1326-5377.2001.tb143553.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Nelson, Mark. "Trials on trial." New Scientist 209, no. 2800 (2011): 30. http://dx.doi.org/10.1016/s0262-4079(11)60384-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Vulto, Arnold G. "Clinical trials on trial." European Journal of Hospital Pharmacy 19, no. 4 (2012): 347. http://dx.doi.org/10.1136/ejhpharm-2012-000180.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Karki, Naresh. "â€œSolidarity Trialâ€: A Feeling of Trust Towards COVID-19 Treatments." Journal of Lumbini Medical College 8, no. 1 (2020): 164–65. http://dx.doi.org/10.22502/jlmc.v8i1.335.

Pełny tekst źródła

Streszczenie:

Corona Virus Disease (COVID-19) drugs are not being developed at the pace in which the disease is spreading throughout the world. WHO and its partners have announced the worldwide clinical trial on 18th March 2020, known as â€œSolidarity Trialâ€ for greater co-ordination of developments of drugs. â€œSolidarity Trialis an international clinical trial to help find an effective treatment for COVID-19â€. The trial is randomized, open-label and adaptive. This trial will analyze four treatment options against standard of care, after recruiting patients from various countries, and then will approac

Style APA, Harvard, Vancouver, ISO itp.

6

Foster, Henry H. "TRIAL MARRIAGES AND DIVORCE TRIALS." Family Court Review 11, no. 1 (2005): 1–7. http://dx.doi.org/10.1111/j.174-1617.1973.tb01183.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Harman, Chloë. "Putting clinical trials on trial." Nature Reviews Nephrology 5, no. 6 (2009): 301. http://dx.doi.org/10.1038/nrneph.2009.89.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

MIZUSHIMA, YUTAKA. "New trials of trial cases." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 29, no. 1/2 (1998): 1–6. http://dx.doi.org/10.3999/jscpt.29.1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Palca, J. "Government ddI trials on trial." Science 246, no. 4935 (1989): 1244. http://dx.doi.org/10.1126/science.2511632.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Moyé, Lemuel A., and Anita Deswal. "Trials within Trials." Controlled Clinical Trials 22, no. 6 (2001): 605–19. http://dx.doi.org/10.1016/s0197-2456(01)00180-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Weinberg, Jeffrey. "Clinical Trials in Progress: ROADS Trial." ONCOLOGY, no. 3508 (August 2021): 495. http://dx.doi.org/10.46883/onc.2021.3508.0495.

Pełny tekst źródła

Streszczenie:

Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) versus Surgically Targeted Radiation Therapy (STaRT) with GammaTile for Treatment of Newly Diagnosed Metastatic Brain Tumors (ROADS; NCT04365374).

Style APA, Harvard, Vancouver, ISO itp.

12

Dean, Rachel S. "Veterinary clinical trials are on trial." Veterinary Record 181, no. 8 (2017): 193–94. http://dx.doi.org/10.1136/vr.j3867.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Ranganathan, Priya, Vishal Deo, C. S. Pramesh, and Mahesh P. Parmar. "Novel trial designs: Master protocol trials." Perspectives in Clinical Research 16, no. 1 (2024): 50–53. https://doi.org/10.4103/picr.picr_214_24.

Pełny tekst źródła

Streszczenie:

Abstract Conventional trial designs are resource and time-intensive. To accelerate the process of testing new interventions, we now have several novel research trial designs. This article focuses on master protocol trials, which allow several therapies to be tested within a single larger trial.

Style APA, Harvard, Vancouver, ISO itp.

14

Rokhsefat, Sana, Deanna E. Morra, Martin Offringa, Lisa M. Askie, and Lauren E. Kelly. "Trial registration in pediatric surgery trials." Journal of Pediatric Surgery 53, no. 7 (2018): 1273–79. http://dx.doi.org/10.1016/j.jpedsurg.2017.10.049.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Curtis, John J., and Bruce Kaplan. "Transplant Immunosuppressive Drug Trials on Trial." American Journal of Transplantation 4, no. 5 (2004): 671–72. http://dx.doi.org/10.1111/j.1600-6143.2004.00474.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Graham, H. Kerr. "The trials of trials." Developmental Medicine & Child Neurology 49, no. 3 (2007): 163. http://dx.doi.org/10.1111/j.1469-8749.2007.00163.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Prashant, Singar* Apurva Torane Mayur Paithankar Anuja Jadhav Sakshi Shahane. "The Importance of Clinical Trials in New Drug Design." International Journal of Pharmaceutical Sciences 2, no. 11 (2024): 530–41. https://doi.org/10.5281/zenodo.14062794.

Pełny tekst źródła

Streszczenie:

Clinical exploration is an elective wording used to portray clinical examination. Clinical exploration includes individuals, and it is for the most part completed to assess the viability of a helpful medication, a clinical/careful strategy, or a gadget as a piece of treatment and patient administration. In addition, any exploration that assesses the parts of an infection like the side effects, risk factors, and pathophysiology, among others may be named clinical examination. Notwithstanding, clinical preliminaries are those reviews that evaluate the capability of a restorative medication/gadge

Style APA, Harvard, Vancouver, ISO itp.

18

Patel, Khushru. "Envisioning Data in Clinical Trials." International Journal of Science and Research (IJSR) 11, no. 9 (2022): 1068. http://dx.doi.org/10.21275/sr22926130141.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Santhosh R Divya, Samuel. "In Silico Clinical Trials - Review." International Journal of Science and Research (IJSR) 12, no. 6 (2023): 262–66. http://dx.doi.org/10.21275/sr23512133636.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

de Vries, Ymkje Anna, Annelieke M. Roest, Erick H. Turner, and Peter de Jonge. "Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials." Psychological Medicine 49, no. 12 (2018): 2020–26. http://dx.doi.org/10.1017/s0033291718002805.

Pełny tekst źródła

Streszczenie:

AbstractBackgroundPrevious studies on reporting bias generally examined whether trials were published in stand-alone publications. In this study, we investigated whether pooled-trials publications constitute a specific form of reporting bias. We assessed whether negative trials were more likely to be exclusively published in pooled-trials publications than positive trials and examined the research questions, individual trial results, and conclusions presented in these articles.MethodsData from a cohort of 105 randomized controlled trials of 16 antidepressants were extracted from earlier public

Style APA, Harvard, Vancouver, ISO itp.

21

Seow, Hsien-Yeang, Patrick Whelan, Mark N. Levine, et al. "Funding Oncology Clinical Trials: Are Cooperative Group Trials Sustainable?" Journal of Clinical Oncology 30, no. 13 (2012): 1456–61. http://dx.doi.org/10.1200/jco.2011.37.2698.

Pełny tekst źródła

Streszczenie:

Purpose Many oncology clinical trials departments (CTDs) are in serious fiscal deficit and their sustainability is in jeopardy. This study investigates whether the payment models used to fund industry versus cooperative group trials contribute to the fiscal deficit of a CTD. Methods We examined the lifetime costs of all cooperative group and industry trials activated in the CTD of a cancer center between 2007 and 2011. A trial's lifetime is defined as being from the date the first patient was accrued until the last patient's actual or projected final follow-up visit. For each trial, we calcula

Style APA, Harvard, Vancouver, ISO itp.

22

Hughes, Emily, Tamara Van Bakel, Ashley Raudanskis, et al. "Comparing the Clinical Trial Characteristics of Industry-Funded Trials and Non Industry-Funded Trials." Journal of Law, Medicine & Ethics 52, no. 3 (2024): 693–700. https://doi.org/10.1017/jme.2024.135.

Pełny tekst źródła

Streszczenie:

AbstractWe compared study characteristics of randomized controlled trials funded by industry (N=697) to those not funded by industry (N=835). RCTs published in high-impact journals are more likely to be blinded, more likely to include a placebo, and more likely to post trial results on ClinicalTrials.gov. Our findings emphasize the importance of evaluating the quality of an RCT based on its methodological rigor, not its funder type.

Style APA, Harvard, Vancouver, ISO itp.

23

Zarin, Deborah A., and Robert M. Califf. "Trial Reporting and the Clinical Trials Enterprise." JAMA Internal Medicine 181, no. 8 (2021): 1131. http://dx.doi.org/10.1001/jamainternmed.2021.2041.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Abd alamir, Moshrik, Susan S. Ellenberg, Ronald S. Swerdloff, et al. "The Cardiovascular Trial of the Testosterone Trials." Coronary Artery Disease 27, no. 2 (2016): 95–103. http://dx.doi.org/10.1097/mca.0000000000000321.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Pardini, Matteo, Gary Cutter, and Maria Pia Sormani. "Clinical trial design for progressive MS trials." Multiple Sclerosis Journal 23, no. 12 (2017): 1642–48. http://dx.doi.org/10.1177/1352458517729461.

Pełny tekst źródła

Streszczenie:

The design of clinical trials is a key aspect to maximizing the possibility to detect a treatment effect. This fact is particularly challenging in progressive multiple sclerosis (PMS) studies due to the uncertainty about the right target and/or outcome in phase-2 studies. The aim of this review is to evaluate the current challenges facing the design of clinical trials for PMS. The selection of patients, the instrumental and clinical outcomes that can be used in PMS trials, and issues in their design will be covered in this report.

Style APA, Harvard, Vancouver, ISO itp.

26

Van Roessel, I. M. A. A., N. I. Mazur, S. K. Shah, L. Bont, and R. Van Der Graaf. "Post-trial Access in Maternal Vaccine Trials." American Journal of Perinatology 36, S 02 (2019): S41—S47. http://dx.doi.org/10.1055/s-0039-1691799.

Pełny tekst źródła

Streszczenie:

AbstractProvisions for post-trial access (PTA) of the experimental intervention are required before the start of a clinical trial. Although there has been ample attention for PTA in the context of preventive vaccine research, discussions on PTA barely include maternal vaccine trials in which mother–infant pairs are exposed to the intervention. In maternal vaccination trials, specific PTA arrangements are required because pregnancy is transient and PTA may apply to the next pregnancy or the child. In this article, we examine the application and adherence to PTA in the context of maternal vaccin

Style APA, Harvard, Vancouver, ISO itp.

27

Ying, Xiangji, and Stephan Ehrhardt. "Pilot Trial Characteristics, Postpilot Design Modifications, and Feasibility of Full-Scale Trials." JAMA Network Open 6, no. 9 (2023): e2333642. http://dx.doi.org/10.1001/jamanetworkopen.2023.33642.

Pełny tekst źródła

Streszczenie:

ImportancePilot trials often lead to study design changes in subsequent full-scale trials. Yet, it remains unclear whether these modifications improve the feasibility of the larger trial.ObjectiveTo compare feasibility estimates between pilot and full-scale trials and identify pilot trial characteristics and modifications associated with equivalent or improved feasibility in the full-scale trial.Design, Setting, and ParticipantsThis cohort study used pilot trials published between January 2005 and December 2018 and their corresponding full-scale trials. PubMed was searched for trials on Februa

Style APA, Harvard, Vancouver, ISO itp.

28

Smigel, K. "The Trials of Prevention Trials." JNCI Journal of the National Cancer Institute 81, no. 15 (1989): 1123–26. http://dx.doi.org/10.1093/jnci/81.15.1123.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

The Lancet. "The trials of tenofovir trials." Lancet 365, no. 9465 (2005): 1111. http://dx.doi.org/10.1016/s0140-6736(05)71850-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Sedgwick, P. "Explanatory trials versus pragmatic trials." BMJ 349, no. 13 3 (2014): g6694. http://dx.doi.org/10.1136/bmj.g6694.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Sibbald, B., and C. Roberts. "Understanding controlled trials: Crossover trials." BMJ 316, no. 7146 (1998): 1719–20. http://dx.doi.org/10.1136/bmj.316.7146.1719.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

McKhann, G. M. "The Trials of Clinical Trials." Archives of Neurology 46, no. 6 (1989): 611–14. http://dx.doi.org/10.1001/archneur.1989.00520420029020.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Munayco-Guillén, Fernando, Hilbert Cevallos-Alvarado, Susy Bazán-Ruiz, Omar Espinoza-Yovera, and Rafael Pichardo-Rodríguez. "Características y tendencias de los ensayos clínicos sobre tratamientos en leucemias: análisis del Registro Peruano de Ensayos Clínicos (1995-2024)." Revista de la Facultad de Medicina Humana 25, no. 1 (2025): 126–32. https://doi.org/10.25176/rfmh.v2025i1.6825.

Pełny tekst źródła

Streszczenie:

To describe the characteristics and trends of clinical trials (CTs) on leukemia registered in the Peruvian Clinical Trial Registry (REPEC, by its Spanish acronym), a descriptive study was conducted on CTs registered between 1995 and July 2024. The REPEC database was searched using the term “leukemia.” Included were CTs involving patients with acute or chronic leukemias, regardless of disease stage or prior treatment. Variables analyzed included type of leukemia, trial phase, type of product, sponsor, international registration, type of outcome, and methodological characteristics. Out of 2,058

Style APA, Harvard, Vancouver, ISO itp.

34

Feizabadi, Mansoureh, Fatima Fahimnia, Alireza Mosavi Jarrahi, Nader Naghshineh, and Shahram Tofighi. "Iranian clinical trials: An analysis of registered trials in International Clinical Trial Registry Platform (ICTRP)." Journal of Evidence-Based Medicine 10, no. 2 (2017): 91–96. http://dx.doi.org/10.1111/jebm.12248.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Kuznetsova, Yulia А., and Anna V. Smirnova. "Bulletin of Clinical Studies in Q1 2021." City Healthcare 2, no. 2 (2021): 101–8. http://dx.doi.org/10.47619/2713-2617.zm.2021.v2i2;101-108.

Pełny tekst źródła

Streszczenie:

Purpose. To evaluate clinical trials data since January 2021 till March 2021. Materials and methods. The information about clinical trial’s approvals from the state register of medicines of Russian Federation ministry of health website was used as the main source of the original data concerning clinical trials. The register contains all the information relating to clinical trials in Russian Federation. Results. Clinical trials data was analyzed by its type (international, local, bioequivalence), sponsorship (foreign, local), phases and disease areas. Separately COVID-19 clinical trials were co

Style APA, Harvard, Vancouver, ISO itp.

36

Bhatt, Arun. "New clinical trial rules: Academic trials and tribulations." Perspectives in Clinical Research 10, no. 3 (2019): 103. http://dx.doi.org/10.4103/picr.picr_103_19.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Nagele, Peter. "The Importance of Definitive Trials: The VIXIE Trial." Anesthesiology 136, no. 3 (2022): 403–4. http://dx.doi.org/10.1097/aln.0000000000004144.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Schoenfeld, D. "Optimizing phase II clinical trials: novel trial designs." Journal of the Peripheral Nervous System 19, S2 (2014): S18—S20. http://dx.doi.org/10.1111/jns.12081_3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Allen, Mary, Heidi Israel, Kyle Rybczyk, et al. "Trial-Related Discrimination in HIV Vaccine Clinical Trials." AIDS Research and Human Retroviruses 17, no. 8 (2001): 667–74. http://dx.doi.org/10.1089/088922201750236942.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Bousquet, Philippe Jean, Pascal Demoly, Giovanni Passalacqua, G. Walter Canonica, and Jean Bousquet. "Immunotherapy: clinical trials – optimal trial and clinical outcomes." Current Opinion in Allergy and Clinical Immunology 7, no. 6 (2007): 561–66. http://dx.doi.org/10.1097/aci.0b013e3282f1d6a4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Reed, N., and N. Siddiqui. "Trials and tribulations: obstacles to clinical trial recruitment." British Journal of Cancer 89, no. 6 (2003): 957–58. http://dx.doi.org/10.1038/sj.bjc.6601233.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Brady, M. F., J. T. Thigpen, J. B. Vermorken, and M. K. B. Parmar. "Randomised trials in ovarian cancer: trial design considerations." Annals of Oncology 10 (1999): S75—S82. http://dx.doi.org/10.1016/s0923-7534(20)31489-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Simberkoff, Michael S. "A tale of two vaccine trials: Trial 1." Current Infectious Disease Reports 4, no. 3 (2002): 235. http://dx.doi.org/10.1007/s11908-002-0084-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Simberkoff, Michael S. "A tale of two vaccine trials: Trial 2." Current Infectious Disease Reports 4, no. 3 (2002): 236–37. http://dx.doi.org/10.1007/s11908-002-0085-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Whitehead, John, Anne Whitehead, Susan Todd, Kim Bolland, and M. Roshini Sooriyarachchi. "Mid-trial design reviews for sequential clinical trials." Statistics in Medicine 20, no. 2 (2001): 165–76. http://dx.doi.org/10.1002/1097-0258(20010130)20:2<165::aid-sim649>3.0.co;2-a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Millar, Courtney, Kathryn Baldyga, Ikechukwu Iloputaife, Alex Wolfe, Jasmin Kuo, and Lewis Lipsitz. "TRIALS AND TRIBULATIONS OF CONDUCTING A GEROSCIENCE TRIAL." Innovation in Aging 7, Supplement_1 (2023): 1144. http://dx.doi.org/10.1093/geroni/igad104.3673.

Pełny tekst źródła

Streszczenie:

Abstract Emerging trials of geroscience interventions show great promise in preventing age-related diseases and disabilities. However, there are many challenges that need to be considered when conducting such trials. Our objective is to describe the major challenges when conducting a geroscience intervention, utilizing the STAMINA study as an example. The STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging) study is a single-arm geroscience-motivated pilot study in which 12 older adults with mild cognitive impairment and slow gait speed are asked to take 12 d

Style APA, Harvard, Vancouver, ISO itp.

47

Qureshi, Riaz. "Overview of clinical trials: trial designs and reporting." Biomedical & Life Sciences Collection 2025, no. 3 (2025): e1006740. https://doi.org/10.69645/dzyh5628.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Qureshi, Riaz. "Overview of clinical trials: history and trial elements." Biomedical & Life Sciences Collection 2025, no. 3 (2025): e1006715. https://doi.org/10.69645/iizg8884.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Frizell, John. "Trials." Nature 509, no. 7501 (2014): 526. http://dx.doi.org/10.1038/509526a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Ramamurthy, NV. "Inept media trials of clinical trials." Perspectives in Clinical Research 3, no. 2 (2012): 47. http://dx.doi.org/10.4103/2229-3485.96442.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!